Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to ...
Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...
committing $1.65 billion up front to partner on a clinical-stage Zealand Pharma molecule with the potential to be a standalone treatment and part of drug combinations for weight loss. The deal ...
Basel: Roche has announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results